Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine

Cancer Res. 1967 Nov;27(11):2129-36.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adult
  • Aged
  • Animals
  • Bromodeoxyuridine / therapeutic use*
  • Carcinoma / drug therapy
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Colonic Neoplasms / drug therapy
  • Deoxyuridine / blood
  • Deoxyuridine / therapeutic use*
  • Deoxyuridine / toxicity
  • Deoxyuridine / urine
  • Dogs
  • Female
  • Floxuridine / therapeutic use*
  • Gallbladder Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Ileocecal Valve
  • Intestinal Neoplasms / drug therapy
  • Liver Neoplasms
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy
  • Rectal Neoplasms / drug therapy
  • Sarcoma / drug therapy
  • Stomach Neoplasms / drug therapy

Substances

  • Floxuridine
  • Bromodeoxyuridine
  • Deoxyuridine